Escend Pharmaceuticals, Inc., Receives IND Clearance from the FDA for ES-3000 Phase I Study in Relapsed or Refractory Acute Myeloid Leukemia (AML)
MENLO PARK, Calif., July 15, 2022 /PRNewswire/ — Escend Pharmaceuticals, Inc., a privately held company focused on the development of small molecule therapeutics for oncology orphan diseases, announced today that the United States Food and Drug Administration (FDA) has cleared its investigational new drug (IND) application for its lead drug candidate, ES-3000 for a Phase I […]
Stem cells saving lives from heart birth defects
Stems Cells are being used to help revitalize the hearts of babies who suffer from a severe heart defect and sometimes prevent the need for a transplant. Video Transcript: Almost 1 out of 100 babies is born with a heart defect. Each year in the U.S. many of these babies will need surgery within weeks […]
Global Induced Pluripotent Stem Cell (iPSC) Market Report 2022: Vast Potential in Cell Therapy, Disease Modelling, Drug Development and Discovery, Personalized Medicine & Toxicology Testing
DUBLIN, July 13, 2022 /PRNewswire/ — The “Global Induced Pluripotent Stem Cell (iPSC) Industry Report, 2022” report has been added to ResearchAndMarkets.com’s offering. Since the discovery of induced pluripotent stem cell (iPSC) technology in 2006, significant progress has been made in stem cell biology and regenerative medicine. New pathological mechanisms have been identified and explained, new […]
Stem Cell Clinic in Mexico That Successfully Treated Gordie Howe Launches Massive Program For American and Canadian Stroke Patients
SAN DIEGO, July 12, 2022 /PRNewswire/ — Novastem, the largest stem cell clinic in Mexico, has launched a brand new protocol aimed at American and Canadian stroke patients. The stem cell protocol accelerates physical recovery after a stroke, and in some cases, when applied early enough, may stop the advancement of all sorts of damage. […]
Understanding Human Pluripotent Stem Cell States and Their Applications with Thorold Theunissen
Thorold Theunissen, Ph.D., of the Washington University School of Medicine in St. Louis shares his work using naive stem cells to model trophoblast development. Video Transcript: [MUSIC] My lab studies human pluripotent stem cells. We’re especially interested in understanding different stem cell states and their applications. Recently, we’ve become really excited about using naive stem […]
Stem Cell Assays Market Report 2022-2027: Government Initiatives to Boost Stem Cell Research Present Opportunities
DUBLIN, July 7, 2022 /PRNewswire/ — The “Stem Cell Assays Market by Type (Viability, Proliferation, Differentiation, Apoptosis), Cell Type (Mesenchymal, iPSCs, HSCs, hESCs), Product & Service (Instrument), Application (Regenerative Medicine, Clinical Research), End User – Global Forecast to 2027” report has been added to ResearchAndMarkets.com’s offering. The stem cell assay market is projected to reach […]
Akari Therapeutics Announces First Patient to Complete Course of Treatment in the Phase III Part A Clinical Trial of Investigational Nomacopan in Pediatric Hematopoietic Stem Cell Transplant-Related Thrombotic Microangiopathy (HSCT-TMA)
NEW YORK and LONDON, July 07, 2022 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biotechnology company focused on developing advanced therapies for autoimmune and inflammatory diseases, today announced that a patient has completed the course of investigational nomacopan treatment in the open-label, multi-center Phase III Part A clinical trial in pediatric hematopoietic stem cell transplant-related […]
ISSCR 2022: On the Ground | The Stem Cell Podcast
In this special episode of the Stem Cell Podcast, Daylon and Arun talk with delegates at the ISSCR 2022 annual meeting. The attendees discuss the memorable research presented and share their thoughts on the challenges facing the stem cell field.
Inceptor Bio Announces Strategic Collaboration with University of Minnesota to Develop Novel iPSC Platform for the Advancement of Next-Generation Allogeneic Cell Therapies
MORRISVILLE, N.C., June 30, 2022 /PRNewswire/ — Inceptor Bio, a biotechnology company advancing cell therapies for difficult-to-treat cancers, today announced a collaboration with University of Minnesota. The aim of this collaboration is to build a novel induced pluripotent stem cells (iPSC) platform that will accelerate Inceptor Bio’s best-in-class next-generation cell therapies platforms. Under the terms of […]
The 2022 Ogawa-Yamanaka Stem Cell Prize Awarded to Juan Carlos Izpisua Belmonte
SAN FRANCISCO, June 28, 2022 /PRNewswire/ — Juan Carlos Izpisua Belmonte, PhD, was announced today as the recipient of the 2022 Ogawa-Yamanaka Stem Cell Prize by Gladstone Institutes. Izpisua Belmonte is director of the San Diego Institute of Science of Altos Labs, a new life sciences company focused on restoring cell health and resilience through […]